Comparison of endometrial biopsy and urinary pregnanediol glucuronide concentration in the diagnosis of luteal phase defect

M. M. Miller, D. I. Hoffman, Mitchell D Creinin, J. H. Levin, R. T. Chatterton, T. Murad, R. W. Rebar

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

To determine if pregnanediol glucuronide (PG) excretion is useful in luteal phase assessment, we compared daily first morning urinary PG concentrations during the luteal phase in nine normal and nine deficient cycles. Total luteal pregnanediol excretion (44.1 ± 11.3 versus 64.0 ± 11.6 area units ± SEM) was not different. However, significantly less pregnanediol was excreted by the abnormal group during the 1st 5 days of the luteal phase (12.7 ± 1.2 versus 18.0 ± 1.7 area units ± SEM, respectively). Thus, delayed PG excretion may be characteristic of luteal phase defect and measurement of urinary PG may be useful only if daily samples during the early luteal phase are obtained.

Original languageEnglish (US)
Pages (from-to)1008-1011
Number of pages4
JournalFertility and Sterility
Volume54
Issue number6
StatePublished - 1990
Externally publishedYes

Fingerprint

Pregnanediol
Luteal Phase
Glucuronides
Biopsy
Corpus Luteum

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Miller, M. M., Hoffman, D. I., Creinin, M. D., Levin, J. H., Chatterton, R. T., Murad, T., & Rebar, R. W. (1990). Comparison of endometrial biopsy and urinary pregnanediol glucuronide concentration in the diagnosis of luteal phase defect. Fertility and Sterility, 54(6), 1008-1011.

Comparison of endometrial biopsy and urinary pregnanediol glucuronide concentration in the diagnosis of luteal phase defect. / Miller, M. M.; Hoffman, D. I.; Creinin, Mitchell D; Levin, J. H.; Chatterton, R. T.; Murad, T.; Rebar, R. W.

In: Fertility and Sterility, Vol. 54, No. 6, 1990, p. 1008-1011.

Research output: Contribution to journalArticle

Miller, MM, Hoffman, DI, Creinin, MD, Levin, JH, Chatterton, RT, Murad, T & Rebar, RW 1990, 'Comparison of endometrial biopsy and urinary pregnanediol glucuronide concentration in the diagnosis of luteal phase defect', Fertility and Sterility, vol. 54, no. 6, pp. 1008-1011.
Miller, M. M. ; Hoffman, D. I. ; Creinin, Mitchell D ; Levin, J. H. ; Chatterton, R. T. ; Murad, T. ; Rebar, R. W. / Comparison of endometrial biopsy and urinary pregnanediol glucuronide concentration in the diagnosis of luteal phase defect. In: Fertility and Sterility. 1990 ; Vol. 54, No. 6. pp. 1008-1011.
@article{ec1851d5a1a941b8afc56e140fada3bd,
title = "Comparison of endometrial biopsy and urinary pregnanediol glucuronide concentration in the diagnosis of luteal phase defect",
abstract = "To determine if pregnanediol glucuronide (PG) excretion is useful in luteal phase assessment, we compared daily first morning urinary PG concentrations during the luteal phase in nine normal and nine deficient cycles. Total luteal pregnanediol excretion (44.1 ± 11.3 versus 64.0 ± 11.6 area units ± SEM) was not different. However, significantly less pregnanediol was excreted by the abnormal group during the 1st 5 days of the luteal phase (12.7 ± 1.2 versus 18.0 ± 1.7 area units ± SEM, respectively). Thus, delayed PG excretion may be characteristic of luteal phase defect and measurement of urinary PG may be useful only if daily samples during the early luteal phase are obtained.",
author = "Miller, {M. M.} and Hoffman, {D. I.} and Creinin, {Mitchell D} and Levin, {J. H.} and Chatterton, {R. T.} and T. Murad and Rebar, {R. W.}",
year = "1990",
language = "English (US)",
volume = "54",
pages = "1008--1011",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Comparison of endometrial biopsy and urinary pregnanediol glucuronide concentration in the diagnosis of luteal phase defect

AU - Miller, M. M.

AU - Hoffman, D. I.

AU - Creinin, Mitchell D

AU - Levin, J. H.

AU - Chatterton, R. T.

AU - Murad, T.

AU - Rebar, R. W.

PY - 1990

Y1 - 1990

N2 - To determine if pregnanediol glucuronide (PG) excretion is useful in luteal phase assessment, we compared daily first morning urinary PG concentrations during the luteal phase in nine normal and nine deficient cycles. Total luteal pregnanediol excretion (44.1 ± 11.3 versus 64.0 ± 11.6 area units ± SEM) was not different. However, significantly less pregnanediol was excreted by the abnormal group during the 1st 5 days of the luteal phase (12.7 ± 1.2 versus 18.0 ± 1.7 area units ± SEM, respectively). Thus, delayed PG excretion may be characteristic of luteal phase defect and measurement of urinary PG may be useful only if daily samples during the early luteal phase are obtained.

AB - To determine if pregnanediol glucuronide (PG) excretion is useful in luteal phase assessment, we compared daily first morning urinary PG concentrations during the luteal phase in nine normal and nine deficient cycles. Total luteal pregnanediol excretion (44.1 ± 11.3 versus 64.0 ± 11.6 area units ± SEM) was not different. However, significantly less pregnanediol was excreted by the abnormal group during the 1st 5 days of the luteal phase (12.7 ± 1.2 versus 18.0 ± 1.7 area units ± SEM, respectively). Thus, delayed PG excretion may be characteristic of luteal phase defect and measurement of urinary PG may be useful only if daily samples during the early luteal phase are obtained.

UR - http://www.scopus.com/inward/record.url?scp=0025608752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025608752&partnerID=8YFLogxK

M3 - Article

C2 - 2245826

AN - SCOPUS:0025608752

VL - 54

SP - 1008

EP - 1011

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 6

ER -